Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 7 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1572904 |
| 301 | 3 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY//LEVOSIMENDAN//PHARMACOLOGY & PHARMACY | 41522 |
| 3965 | 2 | DIHYDRALAZINE SULFATE//TRIMELAMOL//HYDRALAZINE | 843 |
| 21642 | 1 | DIHYDRALAZINE SULFATE//HYDRALAZINE//HYDRALAZINE HYDROCHLORIDE | 434 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | DIHYDRALAZINE SULFATE | authKW | 302575 | 1% | 83% | 5 |
| 2 | HYDRALAZINE | authKW | 240363 | 8% | 9% | 35 |
| 3 | HYDRALAZINE HYDROCHLORIDE | authKW | 165036 | 1% | 45% | 5 |
| 4 | HYDRAZINOPYRIDAZINES | authKW | 145237 | 0% | 100% | 2 |
| 5 | CADRALAZINE | authKW | 108925 | 1% | 50% | 3 |
| 6 | 1 4 DITHIOTHREITOL DTT AS STABILIZER | authKW | 72618 | 0% | 100% | 1 |
| 7 | 2 HYDROXY 1 NAPHTHALDEHYDE DERIVATIZATION | authKW | 72618 | 0% | 100% | 1 |
| 8 | APRESSINUM | authKW | 72618 | 0% | 100% | 1 |
| 9 | BUDRALAZINE | authKW | 72618 | 0% | 100% | 1 |
| 10 | BURNABY HOSP PHARM | address | 72618 | 0% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Pharmacology & Pharmacy | 4154 | 56% | 0% | 245 |
| 2 | Chemistry, Medicinal | 618 | 12% | 0% | 51 |
| 3 | Chemistry, Analytical | 223 | 11% | 0% | 48 |
| 4 | Cardiac & Cardiovascular System | 90 | 7% | 0% | 30 |
| 5 | Toxicology | 63 | 4% | 0% | 19 |
| 6 | Chemistry, Multidisciplinary | 49 | 10% | 0% | 43 |
| 7 | Peripheral Vascular Diseases | 44 | 4% | 0% | 16 |
| 8 | Pathology | 30 | 3% | 0% | 13 |
| 9 | Medicine, General & Internal | 19 | 5% | 0% | 21 |
| 10 | Medicine, Research & Experimental | 18 | 4% | 0% | 16 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | BURNABY HOSP PHARM | 72618 | 0% | 100% | 1 |
| 2 | CIDAT SA CV | 72618 | 0% | 100% | 1 |
| 3 | CLIN CHEM TOXICOL SECT | 72618 | 0% | 100% | 1 |
| 4 | INVEST ANAL ALIMENTANOS | 72618 | 0% | 100% | 1 |
| 5 | NUTR ENVIRONM SCI ORGAN CHEM | 72618 | 0% | 100% | 1 |
| 6 | PREVENT MED INTERNAL MED PHARMACOL | 72618 | 0% | 100% | 1 |
| 7 | SURREY MEM HOSP PHARM | 72618 | 0% | 100% | 1 |
| 8 | SYNTH NAT FUNCT MOL CHEM CHEM | 72618 | 0% | 100% | 1 |
| 9 | VACCINE MED | 24205 | 0% | 33% | 1 |
| 10 | ENVIRONM BIOPHYS | 18153 | 0% | 25% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | REVUE ROUMAINE DE BIOCHIMIE | 28883 | 3% | 4% | 11 |
| 2 | EXPERIMENTAL PATHOLOGY | 3530 | 1% | 1% | 6 |
| 3 | ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 3376 | 3% | 0% | 14 |
| 4 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 2913 | 4% | 0% | 17 |
| 5 | FOLIA PHARMACOLOGICA JAPONICA | 2369 | 1% | 1% | 6 |
| 6 | CLINICAL PHARMACOLOGY & THERAPEUTICS | 1750 | 3% | 0% | 12 |
| 7 | EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS | 1637 | 1% | 0% | 6 |
| 8 | ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE | 1565 | 2% | 0% | 7 |
| 9 | BIOMEDICA BIOCHIMICA ACTA | 1261 | 1% | 0% | 6 |
| 10 | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 1214 | 2% | 0% | 9 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |